{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T02:06:53Z","timestamp":1747188413581,"version":"3.40.5"},"reference-count":89,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T00:00:00Z","timestamp":1628121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Dermatology"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:sec><jats:label\/><jats:p>Autoimmune blistering diseases (AIBDs) are a heterogenous group of skin conditions, broadly classified into two categories depending on the location of blister formation: intraepidermal blistering in the pemphigus group and subepidermal blistering in the pemphigoid group. Although AIBDs occur in both humans and animals, the arsenal of data for human AIBDs far exceeds those of their animal counterpart. Therefore, the main purpose of this review is to highlight existing knowledge, and recent advances in the diagnosis and management of AIBDs in humans \u2013 to serve as a road map for veterinary dermatologists.<\/jats:p><\/jats:sec><jats:sec><jats:title>Areas covered<\/jats:title><jats:p>Recent findings include complement\u2010independent pathways in the pathogenesis of bullous pemphigoid, as well as the role of desmoglein and desmocollin autoantibodies in inducing acantholysis. Systemic glucocorticoids are the mainstay of treatment for AIBDs in humans, yet their long\u2010term use is associated with severe adverse effects and complications, thereby limiting their use. Therefore, researchers have been exploring new and safer alternative therapeutic options for human AIBDs such as anti\u2010CD20 monoclonal antibodies (Rituximab), Bruton\u2019s tyrosine kinase inhibitors (BTKi) and neonatal Fc receptor (FcRn) blockers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Expert opinion<\/jats:title><jats:p>Randomised controlled trial (RCT) level evidence show that Rituximab and short\u2010course GC regimes are more effective and safer than traditional GC treatment for human AIBDs. FcRn blockers such as SYNT001 have shown positive results in preliminary phase 2 clinical trials for treatment of human pemphigus; further trials are required. Rilzabrutinib (PRN1008), an orally administered BTKi, has recently completed phase 2 trials in pemphigus and is in a phase 3 RCT in humans.<\/jats:p><\/jats:sec>","DOI":"10.1111\/vde.13008","type":"journal-article","created":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T10:11:40Z","timestamp":1628158300000},"page":"524","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["State\u2010of\u2010the\u2010art review of human autoimmune blistering diseases (AIBD)"],"prefix":"10.1111","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1383-2845","authenticated-orcid":false,"given":"Faith A.P.","family":"Zeng","sequence":"first","affiliation":[{"name":"University of New South Wales Sydney Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2971-0199","authenticated-orcid":false,"given":"Dedee F.","family":"Murrell","sequence":"additional","affiliation":[{"name":"University of New South Wales Sydney Australia"},{"name":"Department of Dermatology St George Hospital Sydney Australia"},{"name":"The George Institute for Global Health Sydney Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,8,5]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2019.1559291"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(81)70083-5"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1983.tb22223.x"},{"key":"e_1_2_9_5_1","first-page":"291\u2010e71","article-title":"Efficacy of a Bruton's Tyrosine Kinase Inhibitor (PRN\u2010473) in the treatment of canine pemphigus foliaceus","volume":"31","author":"Goodale EC","year":"2020","journal-title":"Vet Dermatol"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2011.03.013"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.26"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/med.21310"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt.12.67"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-017-8662-z"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2011.03.004"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.01.047"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08971.x"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2015.109"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2010.389"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.06.022"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13409"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01190"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13106"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15679"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-54421-6"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01506"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20199007"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15251"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1400095"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10481.x"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2012.35"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70061-7"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-017-8633-4"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.10.035"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2014.51"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2011.03.005"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2011.03.010"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.756"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2012.11108.x"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2012.04.003"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-018-8986-7"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2011.03.014"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.4103\/2229-5178.198774"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12627611"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2011.03.001"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.13637"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2010.01069.x"},{"key":"e_1_2_9_44_1","doi-asserted-by":"crossref","first-page":"2,010","DOI":"10.4049\/jimmunol.159.4.2010","article-title":"Characterization of autoantibodies in pemphigus using antigen\u2010specific enzyme\u2010linked immunosorbent assays with baculovirus\u2010expressed recombinant desmogleins","volume":"159","author":"Ishii K","year":"1997","journal-title":"J Immunol"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2011.03.003"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.12.032"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-020-0810-y"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.1434"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.8179"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.01.012"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2009.72"},{"key":"e_1_2_9_52_1","first-page":"4","article-title":"Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) in pemphigus","volume":"17","author":"Pf\u00fctze M","year":"2007","journal-title":"Eur J Dermatol"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.04.042"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.06.032"},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.12711"},{"key":"e_1_2_9_56_1","first-page":"410\u2010e110","article-title":"Open trial of Bruton's tyrosine kinase inhibitor (PRN1008) in the treatment of canine pemphigus foliaceus","volume":"31","author":"Goodale EC","year":"2020","journal-title":"Vet Dermatol"},{"key":"e_1_2_9_57_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.4972"},{"key":"e_1_2_9_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12623"},{"key":"e_1_2_9_59_1","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20197198"},{"key":"e_1_2_9_60_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-017-0594-z"},{"key":"e_1_2_9_61_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2737"},{"key":"e_1_2_9_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijwd.2020.03.043"},{"key":"e_1_2_9_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.advms.2016.07.002"},{"key":"e_1_2_9_64_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1996.03890360021005"},{"key":"e_1_2_9_65_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1984.01650370050009"},{"key":"e_1_2_9_66_1","first-page":"13","article-title":"[Treatment of pemphigus vulgaris by azathioprine and low doses of prednisone (Lever scheme)]","volume":"130","author":"Benoit Corven C","year":"2003","journal-title":"Ann Dermatol Venereol"},{"key":"e_1_2_9_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.09.052"},{"key":"e_1_2_9_68_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1984.01650430127024"},{"key":"e_1_2_9_69_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.144.1.25"},{"key":"e_1_2_9_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.02.021"},{"key":"e_1_2_9_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30070-3"},{"key":"e_1_2_9_72_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-019-00497-9"},{"key":"e_1_2_9_73_1","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2019.1670059"},{"key":"e_1_2_9_74_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01418"},{"key":"e_1_2_9_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2017.11.005"},{"key":"e_1_2_9_76_1","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.1003a50"},{"key":"e_1_2_9_77_1","first-page":"CD002292","article-title":"Interventions for bullous pemphigoid","volume":"2010","author":"Kirtschig G","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_9_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/0738-081X(87)90060-5"},{"key":"e_1_2_9_79_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13717"},{"key":"e_1_2_9_80_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2885.2010.01174.x"},{"key":"e_1_2_9_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2011.06.003"},{"key":"e_1_2_9_82_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1993.01680220061016"},{"key":"e_1_2_9_83_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12072"},{"key":"e_1_2_9_84_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01318-8"},{"key":"e_1_2_9_85_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm7040062"},{"key":"e_1_2_9_86_1","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0000000000000412"},{"key":"e_1_2_9_87_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01540"},{"key":"e_1_2_9_88_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aax9586"},{"key":"e_1_2_9_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.102366"},{"key":"e_1_2_9_90_1","unstructured":"ClinicalTrials.gov website.A Safety and Dose\u2010Finding Study of SYNT001 in Subjects With Pemphigus (Vulgaris or Foliaceus). Available at:https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03075904. Accessed Mar 25 2021."}],"container-title":["Veterinary Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/vde.13008","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/vde.13008","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/vde.13008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T23:37:38Z","timestamp":1693006658000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/vde.13008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,5]]},"references-count":89,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10.1111\/vde.13008"],"URL":"https:\/\/doi.org\/10.1111\/vde.13008","archive":["Portico"],"relation":{},"ISSN":["0959-4493","1365-3164"],"issn-type":[{"type":"print","value":"0959-4493"},{"type":"electronic","value":"1365-3164"}],"subject":[],"published":{"date-parts":[[2021,8,5]]},"assertion":[{"value":"2021-01-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}